Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Fiona C. Burkhard is a leading urologic surgeon and researcher whose work has fundamentally shaped the management of muscle-invasive bladder cancer and the long-term care of patients requiring urinary diversion. She is best known for her landmark 2015 paper, "Open radical cystectomy: still the gold standard for muscle invasive bladder cancer," which has garnered 48 citations and remains a cornerstone reference in the field, defending the role of open surgery amidst the rise of minimally invasive techniques. Dr. Burkhard also co-authored the authoritative "Update of the ICUD–SIU International Consultation on Bladder Cancer 2018: urinary diversion," a 27-cited consensus document that sets global standards for post-cystectomy care. Demonstrating remarkable forward-thinking, she is now pioneering next-generation solutions to the chronic problem of biofilm formation in indwelling medical devices. Her recent 2025 work on "Ultrasound-activated cilia for biofilm control" (8 citations) introduces a novel, non-invasive approach to preventing device encrustation and infection, promising to drastically reduce the need for frequent catheter and stent replacements. Through her blend of clinical gold-standard advocacy and innovative bioengineering, Dr. Burkhard continues to improve both survival and quality of life for urologic patients.